Industries

In this research deliverable, Frost & Sullivan’s senior analyst team across the healthcare sector provide bold perspectives and predictions for the industry in 2015. The markets covered include pharmaceuticals and biotech, medical devices, medical imaging, and healthcare IT, amongst others. The analysis captures the impact of trends which are exp...

The future of three-dimensional bioprinting (3DBP) and its transformation of the healthcare sector will be determined by the breadth and depth of its application potential, and its ability to unleash a whole new world of application segments. From printing a tissue or cells to developing human organs, 3DBP has demonstrated capability in the world o...

In an increasingly independent, mobile and do-it-yourself world, healthcare alone remains rooted in a centralized, professional-controlled setting. However, emerging global megatrends necessitate the need for decentralization of healthcare services and patient empowerment. This research service showcases emerging trends in home healthcare and throw...

With the growing need for better therapeutics, and the current patent cliff that is underway, therapies such as monoclonal antibodies, recombinant protein therapeutics and even vaccines for a whole host of indications are in high demand. Conventionally expression systems were utilized to aid in the development and production of these therapeutics...

Artificial organs are support devices that are either attached to the human body or implanted in the human body to restore the function of an ailing organ or to completely replace a native organ. Artificial organs can be segmented into 7 main categories, that is, cochlear implants, artificial heart, artificial liver, artificial pancreas, artificial...

Medical imaging modalities such as X-ray imaging, magnetic resonance imaging, positron emission tomography, and others, have been designed to capture high resolution images through minimally-invasive approaches. However, each of these also suffer from limitations, foremost of which is that they utilize ionizing radiation that is hazardous to the pa...

Monoclonal antibody therapeutics are being used for treatment of a wide array of diseases, specially in therapeutic areas such as oncology, immunology (including autoimmune and inflammatory diseases, as well as, transplant rejection) and neuroscience. The development of these new molecular agents, successfully directed to specific cellular targets,...

Shifts to how healthcare is delivered, where it is delivered, and how it is paid for are necessitating adoption of innovative tools for managing information. A key challenge is to appropriately assess the importance of various quantitative metrics, as well as correlate with qualitative recommendations and patient history. The voluminous forms of un...

The continued development of new treatments associated with the demographic trends and public health considerations is remarkable. Nanotechnology has been identified as one most relevant key enabling technologies of the last ten years, significantly impacting on many different biomedical developments in a broad spectrum of applications therapeutics...